Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Moxifloxacin impurity 10, also known as ent-Moxifloxacin hydrochloride, is an identified impurity associated with the antibiotic Moxifloxacin. This compound is primarily utilized in analytical chemistry for quality control and regulatory compliance in pharmaceutical development. Researchers may employ this impurity to study its effects in formulations and to ensure the purity of Moxifloxacin in various applications. -
Drug Impurity
Rosuvastatin impurity 51 is a chemical impurity associated with Rosuvastatin, a statin used for cholesterol management. This impurity may play a role in the evaluation of the drug's purity and quality control in pharmaceutical research. It is relevant for studies focused on assessing the metabolic by-products and potential effects of Rosuvastatin in various biological systems. -
Drug Impurity
Rosuvastatin impurity 48 is a known impurity associated with Rosuvastatin, a statin drug that inhibits HMG-CoA reductase. This impurity can be utilized for analytical and quality control purposes in pharmaceutical research to assess the purity and stability of Rosuvastatin formulations. Its characterization is essential for understanding the compound's behavior in drug development and ensuring regulatory compliance. -
Drug Impurity
Olmesartan impurity 10 is a chemical impurity associated with the antihypertensive agent Olmesartan, primarily affecting its pharmacological profile. This compound can be used in quality control and regulatory compliance studies to assess the purity of Olmesartan formulations. Its characterization is essential for ensuring the safety and efficacy of final drug products in pharmaceutical development. -
Drug Impurity
Naproxen impurity 3 is a chemical impurity associated with Naproxen, a widely used nonsteroidal anti-inflammatory drug (NSAID). This impurity is crucial for assessing the quality and safety of Naproxen in pharmaceutical formulations. It serves as an important reference standard in drug testing and analytical research, aiding researchers in understanding the implications of impurities on drug efficacy and metabolism. -
Drug Impurity
Tenofovir impurity 4 is a minor impurity associated with Tenofovir, an antiretroviral medication. This compound is utilized in pharmaceutical research to assess the quality and stability of Tenofovir formulations. It aids in the evaluation of drug purity and consistency, which is critical for ensuring the safety and efficacy of therapeutic applications. -
Drug Impurity
Apixaban impurity 5 is a chemical impurity associated with the anticoagulant Apixaban. This compound serves as a key reference standard for analytical purposes, particularly in quality control and method validation processes. Its characterization is crucial for ensuring the purity and stability of Apixaban formulations, supporting research into drug efficacy and safety profiles in anticoagulation therapies. -
Drug Impurity
Clarithromycin impurity 14 is a known impurity of the macrolide antibiotic Clarithromycin. Characterized by its potential effects on drug purity, this compound is essential for analytical research and quality control in pharmaceutical formulations. It serves as a reference standard for assessing the presence and concentration of impurities in Clarithromycin products, ensuring compliance with regulatory guidelines. -
Drug Impurity
Pramipexole impurity 4, also known as Pramipexole N6-Ethylamino Analog, is a known impurity associated with the production of Pramipexole. This compound serves as a useful reference standard for analytical methods in drug development and quality control. Its presence can influence the safety and efficacy assessments of Pramipexole formulations, making it vital for research applications focusing on drug purity and stability. -
Drug Impurity
Melatonin impurity 1, also known as N-Acetyl-5-acetoxytryptamine, is an identified impurity of the hormone melatonin. This compound may be utilized in the analysis of melatonin formulations to assess purity and quality. Its presence can provide insights into the synthesis processes and stability profiles of melatonin products in pharmaceutical research and development. -
Drug Impurity
Bupropion impurity 12 is a known impurity of the antidepressant Bupropion. It serves as a reference standard for analyzing drug formulation quality and helps in the identification and quantification of impurities using analytical techniques such as HPLC and mass spectrometry. This impurity can be essential for research applications focused on the safety and efficacy of Bupropion and its metabolites. -
Drug Impurity
Mebendazole impurity 3, also known as 1-Methyl Mebendazole, is a chemical impurity associated with the anthelmintic agent Mebendazole. This compound is significant for quality control and characterization studies in drug formulation processes. Its presence can influence the efficacy and safety profiles of Mebendazole, making it a relevant focus for analytical and pharmacological research. -
Drug Impurity
Betamethasone impurity 2 is a characterized impurity of the corticosteroid Betamethasone, primarily used for research on pharmaceutical quality control. This compound can be used to assess the purity and stability of Betamethasone formulations and is important for understanding the potential impacts of impurities on drug efficacy and safety. Research applications include analytical method development and assessment of drug stability in various formulations. -
Drug Impurity
Leflunomide impurity 1, also known as Leflunomide impurity F, is a chemical reagent identified as an impurity associated with Leflunomide. This compound is primarily utilized in analytical chemistry and pharmaceutical research to ensure the purity and quality of Leflunomide formulations. Its identification and quantification are crucial for compliance with regulatory standards and for understanding the potential effects of impurities in drug metabolism and pharmacokinetics. -
Drug Impurity
Budesonide impurity 86, also known as Budesonide 21-acetate, is a chemical impurity associated with Budesonide. This compound is utilized primarily for analytical and quality control purposes in pharmaceutical research. Its identification and quantification are critical for ensuring the purity and efficacy of Budesonide formulations. Furthermore, it may serve as a reference standard in the evaluation of drug stability and degradation pathways. -
Drug Impurity
Fluocinolone impurity 2 is a specific impurity of the corticosteroid Fluocinolone, primarily identified during the synthesis and formulation processes. This compound is significant in the quality control of Fluocinolone formulations, as the presence of impurities can affect drug efficacy and safety. It is used in pharmaceutical research to assess the purity and stability of corticosteroid products. -
Drug Impurity
Clarithromycin impurity 8, also known as De(cladinosyl) Clarithromycin, is a known impurity associated with the antibiotic Clarithromycin. This compound serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. Its characterization and quantification are essential for ensuring the safety and efficacy of Clarithromycin formulations in pharmaceutical development and compliance testing. -
Drug Impurity
Quetiapine impurity 17 is a known impurity associated with the antipsychotic drug Quetiapine. It is primarily utilized in pharmaceutical research to evaluate the purity and stability of Quetiapine formulations. This compound can assist in the development of analytical methods and quality control processes within drug manufacturing, ensuring compliance with regulatory standards. -
Drug Impurity
Sertraline impurity 12 is a chemical impurity associated with the selective serotonin reuptake inhibitor Sertraline. This compound is utilized primarily in pharmacological studies to assess the purity and quality of Sertraline formulations. It serves as a reference standard in regulatory testing and is essential for understanding the compound's stability and potential effects on efficacy and safety profiles. -
Drug Impurity
Chlorthalidone impurity 8 is a known impurity associated with Chlorthalidone, a thiazide diuretic. This compound is important for analytical chemistry applications, particularly for the characterization and quality control of chlorthalidone formulations. Monitoring impurities such as Chlorthalidone impurity 8 is essential for ensuring the safety and efficacy of pharmaceutical products in compliance with regulatory standards. -
Drug Impurity
Methyl 4-ethoxy-3-oxobutanoate is a drug impurity that may arise during the synthesis of various pharmaceuticals. This compound can serve as a marker for assessing synthesis-related quality control and purity analysis in drug development processes. Its presence can influence the efficacy and safety profiles of therapeutic agents, making it significant for researchers focused on drug formulation and optimization. -
Drug Impurity
Apixaban impurity 45, also known as Apixaban Dehydro impurity, is a recognized impurity associated with the anticoagulant Apixaban. Its characterization is crucial for ensuring the quality and stability of Apixaban formulations. This compound may be utilized in pharmaceutical research to assess the purity and safety profiles of Apixaban and to understand the degradation pathways of the drug. -
Drug Impurity
Brimonidine impurity 4 is a chemical impurity associated with Brimonidine. It is primarily relevant in the characterization and quality control of Brimonidine formulations. This impurity serves as a critical reference standard for analytical methods aimed at ensuring the safety and efficacy of pharmaceutical products containing Brimonidine. Its study aids in understanding the purity profile and stability of the drug. -
Drug Impurity
Etoricoxib impurity 2 is a characterized impurity of the non-steroidal anti-inflammatory drug Etoricoxib, primarily known for its selective inhibition of cyclooxygenase-2 (COX-2). This impurity is important for analytical studies and quality control in pharmaceutical applications, particularly in the assessment of Etoricoxib purity and stability. Research involving this compound contributes to understanding the implications of impurities on drug efficacy and safety profiles. -
Drug Impurity
Duloxetine impurity 5 oxalate is a byproduct of Duloxetine oxalate, specifically the N-methyl (R)-isomer. This compound serves as a critical reference standard for quality control and analytical characterization in pharmaceutical research. Its identification and quantification are essential for ensuring the purity and safety of Duloxetine formulations in drug development studies. -
Drug Impurity
Fluticasone impurity 7, an impurity of Fluticasone, primarily affects steroidal pathways. Its biological activity can provide insights into the degradation and stability of Fluticasone formulations. This compound is essential for analytical research in quality control and regulatory assessments related to pharmaceuticals. -
Drug Impurity
rel-(R,R)-Glycopyrrolate is a drug impurity characterized by its structural configuration as a glycopyrrolate analogue. It is primarily utilized in research to study the pharmacological effects of glycopyrrolate and its related compounds. This reagent is important for understanding impurities in pharmaceutical formulations, which can influence drug efficacy and safety profiles. -
Drug Impurity
Solifenacin impurity 3, also known as Solifenacin impurity D, is a specific impurity associated with Solifenacin. It is essential for quality control and validation in pharmaceutical formulations involving Solifenacin. This impurity serves as an important reference standard for analytical chemistry applications, ensuring the purity and integrity of Solifenacin-based drug products. -
Drug Impurity
Parecoxib sodium impurity 10 is a defined impurity associated with Parecoxib sodium. As a potential drug impurity, it is relevant for pharmacological studies and quality control in the development of non-steroidal anti-inflammatory drugs (NSAIDs). Researchers studying the stability and safety of Parecoxib formulations may find this compound useful for analytical purposes and impurity profiling. -
Drug Impurity
Rivaroxaban impurity 10 is a drug impurity associated with the anticoagulant Rivaroxaban. This compound is essential for quality control and stability testing during pharmaceutical development and manufacturing processes. It may also be used for research purposes to study the metabolic pathways and degradation products of Rivaroxaban, ensuring the integrity and safety of the final pharmaceutical product. -
Drug Impurity
Rifampicin impurity 3 is a chemical impurity associated with the antibiotic Rifampicin. It serves as an important reference standard in the analysis of drug purity and quality control. This compound is utilized in pharmacological research to study the degradation products and stability of Rifampicin, contributing to the understanding of its overall efficacy and safety profile. -
Drug Impurity
Metformin impurity 11, also known as Metformin impurity E, is a known impurity associated with Metformin. This compound is critical for researchers involved in the analysis of drug purity and quality control in pharmaceutical development. Its identification and characterization are important for ensuring the safety and efficacy of Metformin and related formulations. -
Drug Impurity
Pramipexole impurity 1 (2-N-Propyl pramipexole) is a chemical impurity associated with the drug Pramipexole, which targets dopamine receptors. This impurity is essential for quality control and validation studies in pharmaceutical research, ensuring the purity and safety of drug formulations. It serves as a reference compound in analytical chemistry and can facilitate the investigation of drug metabolism and pharmacokinetics. -
Drug Impurity
Escitalopram Impurity 1 is a known impurity linked to the selective serotonin reuptake inhibitor (SSRI) escitalopram. This compound is essential for evaluating the purity and quality of escitalopram in pharmaceutical formulations. Its analysis aids in understanding potential side effects and therapeutic efficacy in drug development and quality control processes. -
Drug Impurity
Itraconazole impurity 13 is a specified impurity derived from Itraconazole. This compound may be relevant for the assessment of drug quality and stability, particularly in pharmaceutical formulations. It is utilized in the characterization of Itraconazole products and can aid in ensuring compliance with regulatory standards during drug development and manufacturing processes. -
Drug Impurity
Itraconazole impurity 9, also known as isopropyl Itraconazole, is a compound associated with the antifungal agent Itraconazole. It serves as a drug impurity that may arise during the synthesis or formulation of Itraconazole. This compound is useful for research applications focused on assessing the purity and stability of pharmaceutical formulations. Its presence can impact the pharmacological properties and safety profile of Itraconazole, making it significant for quality control in drug development. -
Drug Impurity
Aripiprazole impurity 22 is a validated impurity associated with the antipsychotic agent Aripiprazole. This compound is crucial for quality control and method development in pharmacological studies. Its characterization is essential for assessing the purity and safety of Aripiprazole formulations, thereby supporting regulatory compliance in drug development and analytical research. -
Drug Impurity
Alfuzosin EP impurity 6 is a known impurity associated with the pharmaceutical compound Alfuzosin EP. It serves as a reference standard for quality control and analytical studies, particularly in the evaluation of drug purity and compliance with pharmacopoeial specifications. Its presence is critical for assessing the overall safety and efficacy profile of Alfuzosin formulations during drug development and regulatory processes. -
Drug Impurity
Omeprazole impurity 5 is a known impurity associated with the proton pump inhibitor Omeprazole. This chemical reagent is essential for analytical research, particularly in the development and quality control of pharmaceutical formulations. Its presence can affect drug stability and efficacy, making it important for studies focusing on drug metabolism and impurity profiles. -
Drug Impurity
Apixaban impurity 27 is a known impurity of the anticoagulant Apixaban, primarily used for pharmacokinetic and toxicological studies. This compound serves as an essential reference standard for evaluating the purity and quality of Apixaban formulations. It plays a critical role in ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Febuxostat impurity 1 is a chemical impurity associated with the synthesis of Febuxostat, a selective xanthine oxidase inhibitor. This compound serves as a critical standard for analytical development, helping to ensure the quality and consistency of Febuxostat formulations. Researchers can utilize Febuxostat impurity 1 for various applications in stability testing and method validation in pharmaceutical research and development. -
Drug Impurity
Paliperidone impurity 3 hydrochloride is a known impurity of the antipsychotic agent Paliperidone hydrochloride. This compound is valuable for quality control and analytical research to ensure the safety and efficacy of pharmaceutical formulations. Its characterization supports the development of standardized methods for assessing drug purity in pharmaceutical applications. -
Drug Impurity
Dacomitinib impurity 4 is an identified impurity of the targeted cancer therapy Dacomitinib, which functions as a pan-ERBB inhibitor. This reagent is essential for researchers studying the purity and stability of Dacomitinib formulations and supports the evaluation of drug quality in pharmaceutical development. Its analysis contributes to understanding the safety and efficacy of ERBB-targeted therapies in cancer research. -
Drug Impurity
Rosuvastatin impurity 35, also known as Rosuvastatin acid allyl ester, is a chemical impurity associated with the cholesterol-lowering agent Rosuvastatin. This compound serves as an important reference standard for drug quality control and analytical studies, facilitating the assessment of synthetic processes and product purity. It can be utilized in research applications focused on the pharmacokinetics and pharmacodynamics of Rosuvastatin and its derivatives. -
Drug Impurity
Levetiracetam impurity 8 is a characterized impurity of the antiepileptic drug Levetiracetam. It is utilized in analytical and quality control applications within pharmaceutical research to ensure the purity and stability of Levetiracetam formulations. This compound supports the investigation of drug metabolism and assists in the assessment of potential impacts on safety and efficacy profiles. -
Drug Impurity
Aripiprazole impurity 37 is a known impurity associated with the antipsychotic drug Aripiprazole. This compound is critical for analytical assessments, including stability studies and impurity profiling. It serves as a quality control standard in the pharmaceutical industry to ensure the purity and safety of Aripiprazole formulations. Researchers can utilize Aripiprazole impurity 37 for method development and validation in drug characterization. -
Drug Impurity
Acetaminophen Impurity 1 is a recognized impurity of the analgesic compound acetaminophen. This reagent serves as a critical control substance for the analysis and quality assurance of acetaminophen formulations. It is crucial for researchers investigating drug stability, degradation pathways, and the safety profile of acetaminophen-based therapeutics. -
Drug Impurity
Duloxetine impurity 1 is a characterized impurity associated with Duloxetine, a serotonin-norepinephrine reuptake inhibitor. This compound serves as an important reference standard in the pharmaceutical development and quality control of Duloxetine formulations. Its analysis is critical for ensuring the purity and safety of drug products containing this active pharmaceutical ingredient. Research applications include method validation and stability testing in pharmaceutical sciences. -
Drug Impurity
Fluocinolone impurity 3 is a chemical impurity associated with the corticosteroid fluocinolone. It serves as an important reference standard in quality control and analytical studies to assess the purity and identify the composition of fluocinolone formulations. This compound can be utilized in pharmacokinetic studies and stability testing, contributing to the evaluation of drug safety and efficacy in pharmaceutical development. -
Drug Impurity
Atenolol impurity 3 is a chemical impurity associated with the β-adrenergic antagonist Atenolol. It serves as an important reference standard for quality control and analytical testing in pharmaceutical research. This impurity can be utilized to assess the purity profile of Atenolol formulations and support regulatory compliance in drug development.
